Your browser doesn't support javascript.
loading
Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant.
Graham, Carl; Seow, Jeffrey; Huettner, Isabella; Khan, Hataf; Kouphou, Neophytos; Acors, Sam; Winstone, Helena; Pickering, Suzanne; Galao, Rui Pedro; Dupont, Liane; Lista, Maria Jose; Jimenez-Guardeño, Jose M; Laing, Adam G; Wu, Yin; Joseph, Magdalene; Muir, Luke; van Gils, Marit J; Ng, Weng M; Duyvesteyn, Helen M E; Zhao, Yuguang; Bowden, Thomas A; Shankar-Hari, Manu; Rosa, Annachiara; Cherepanov, Peter; McCoy, Laura E; Hayday, Adrian C; Neil, Stuart J D; Malim, Michael H; Doores, Katie J.
Afiliación
  • Graham C; Department of Infectious Diseases, School of Immunology & Microbial Sciences, King's College London, London, UK.
  • Seow J; Department of Infectious Diseases, School of Immunology & Microbial Sciences, King's College London, London, UK.
  • Huettner I; Department of Infectious Diseases, School of Immunology & Microbial Sciences, King's College London, London, UK.
  • Khan H; Department of Infectious Diseases, School of Immunology & Microbial Sciences, King's College London, London, UK.
  • Kouphou N; Department of Infectious Diseases, School of Immunology & Microbial Sciences, King's College London, London, UK.
  • Acors S; Department of Infectious Diseases, School of Immunology & Microbial Sciences, King's College London, London, UK.
  • Winstone H; Department of Infectious Diseases, School of Immunology & Microbial Sciences, King's College London, London, UK.
  • Pickering S; Department of Infectious Diseases, School of Immunology & Microbial Sciences, King's College London, London, UK.
  • Galao RP; Department of Infectious Diseases, School of Immunology & Microbial Sciences, King's College London, London, UK.
  • Dupont L; Department of Infectious Diseases, School of Immunology & Microbial Sciences, King's College London, London, UK.
  • Lista MJ; Department of Infectious Diseases, School of Immunology & Microbial Sciences, King's College London, London, UK.
  • Jimenez-Guardeño JM; Department of Infectious Diseases, School of Immunology & Microbial Sciences, King's College London, London, UK.
  • Laing AG; Peter Gorer Department of Immunobiology, School of Immunology & Microbial Sciences, King's College London, London, UK.
  • Wu Y; Peter Gorer Department of Immunobiology, School of Immunology & Microbial Sciences, King's College London, London, UK; The Francis Crick Institute, UK.
  • Joseph M; Peter Gorer Department of Immunobiology, School of Immunology & Microbial Sciences, King's College London, London, UK; The Francis Crick Institute, UK.
  • Muir L; Division of Infection and Immunity, University College London, London, UK.
  • van Gils MJ; Department of Medical Microbiology, Academic Medical Center, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Netherlands.
  • Ng WM; Division of Structural Biology, Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
  • Duyvesteyn HME; Division of Structural Biology, Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
  • Zhao Y; Division of Structural Biology, Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
  • Bowden TA; Division of Structural Biology, Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
  • Shankar-Hari M; Department of Infectious Diseases, School of Immunology & Microbial Sciences, King's College London, London, UK.
  • Rosa A; The Francis Crick Institute, UK.
  • Cherepanov P; The Francis Crick Institute, UK.
  • McCoy LE; Division of Infection and Immunity, University College London, London, UK.
  • Hayday AC; Peter Gorer Department of Immunobiology, School of Immunology & Microbial Sciences, King's College London, London, UK; The Francis Crick Institute, UK.
  • Neil SJD; Department of Infectious Diseases, School of Immunology & Microbial Sciences, King's College London, London, UK; Genotype-to-Phenotype UK National Virology Consortium.
  • Malim MH; Department of Infectious Diseases, School of Immunology & Microbial Sciences, King's College London, London, UK; Genotype-to-Phenotype UK National Virology Consortium.
  • Doores KJ; Department of Infectious Diseases, School of Immunology & Microbial Sciences, King's College London, London, UK; Genotype-to-Phenotype UK National Virology Consortium. Electronic address: katie.doores@kcl.ac.uk.
Immunity ; 54(6): 1276-1289.e6, 2021 06 08.
Article en En | MEDLINE | ID: mdl-33836142
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Glicoproteína de la Espiga del Coronavirus / SARS-CoV-2 / COVID-19 / Anticuerpos Monoclonales / Anticuerpos Antivirales / Epítopos Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Immunity Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Glicoproteína de la Espiga del Coronavirus / SARS-CoV-2 / COVID-19 / Anticuerpos Monoclonales / Anticuerpos Antivirales / Epítopos Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Immunity Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido